Conference & Meetings World Supplements Canada Supplement - Page 18

Toronto Circling for success in Toronto Conference ambassadors from Toronto’s Leaders Circle set up a winning bid that delivered record results for the organisers of the 19th World Conference on Lung Cancer. Case study: The IASLC 19th World Conference on Lung Cancer (#WCLC2018) 23-26 September 2018 Toronto, Canada T he International Association for the Study of Lung Cancer’s (IASLC) 2018 World Conference on Lung Cancer set attendance records when it came to Toronto last September, bringing leading experts dedicated to research and treatment of lung cancer and thoracic malignancies. It was the world’s largest meeting of its kind, setting a record of 7,500 attendees from 100 countries. As well as a record attendance, the conference highlighted the leading work being done in the field in Toronto and in Canada. A collaborative team effort by the teams at Business Events Toronto, Metro Toronto Convention Centre (MTCC) and other local invested businesses helped drive the overall success of the congress. A major role in securing the bid for the event was played by Toronto’s ambassador programme, known as the Leaders Circle programme. Leaders Circle helps provide a transfer of knowledge and promotes 18 CONFERENCE & MEETINGS WORLD 7,443 2,662 3,403 36.3m 11,500+ 2,000+ attendees hashtag impressions participants WCLC2018 tweets innovation and the city’s groundbreaking institutions, as well as highlighting the legacy of social and economic benefits to the city and region from conferences attracted. Honorary chair Dr Frances Shepherd, who holds the Scott Taylor Chair in Lung Cancer Research the Princess Margaret Cancer Centre, helped bring IASLC to Toronto. Dr Shepherd is also a Professor of Medicine at University of Toronto. Under her leadership, the Canadian Clinical Trails Group Lung Cancer Site conducted many international practice-changing studies. These studies showed that post- operative chemotherapy can change the cure rate for resected lung cancer, and that molecularly targeted treatments can improve survival even in the most advanced stages of the disease. She has authored or co-authored more than 500 peer-reviewed publications and 35 book chapters. As well, at IASLC in Toronto, for the first time in the history of the Congress – the app downloads abstracts submitted Honorary Chair, and all three congress Canadian co-Presidents were women – Dr Andrea Bezjak, Dr Gail Darling and Dr Natasha Leighl. The Lung Site Group at Princess Margaret is the largest comprehensive programme in Canada treating lung cancer and other thoracic malignancies. The centre’s Medical Oncology Programme offers a range of Phase I, II and III clinical trials of novel therapies in lung cancer. Members of the team have made major breakthroughs, including: • Establishing the benefit of CT screening in individuals at high risk of lung cancer • Improving the survival of patients with completely resected early-stage non- small-cell lung cancer by administering adjuvant chemotherapy • Demonstrating the palliative benefit of targeted oral agents for patients who have previously received chemotherapy • Establishing best practices in both curative and palliative thoracic radiotherapy.